Your browser doesn't support javascript.
loading
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green, Jennifer B; Bethel, M Angelyn; Armstrong, Paul W; Buse, John B; Engel, Samuel S; Garg, Jyotsna; Josse, Robert; Kaufman, Keith D; Koglin, Joerg; Korn, Scott; Lachin, John M; McGuire, Darren K; Pencina, Michael J; Standl, Eberhard; Stein, Peter P; Suryawanshi, Shailaja; Van de Werf, Frans; Peterson, Eric D; Holman, Rury R.
Affiliation
  • Green JB; From the Duke Clinical Research Institute, Duke University School of Medicine, Durham (J.B.G., J.G., M.J.P., E.D.P.) and University of North Carolina School of Medicine, Chapel Hill (J.B.B.) - both in North Carolina; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom (M.A.B., R.R.H.); Canadian VIGOUR Centre, University of Alberta, Edmonton, AB (P.W.A.) and St. Michael's Hospital, University of Toronto, Toronto (R.J.) - bot
N Engl J Med ; 373(3): 232-42, 2015 Jul 16.
Article in En | MEDLINE | ID: mdl-26052984
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Triazoles / Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: N Engl J Med Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Triazoles / Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: N Engl J Med Year: 2015 Type: Article